Fund Holdings — Spruce Street Capital LP

Total Portfolio Value:
$628.98M
Total Bought:
$628.98M
Total Sold:
$0
Net Transaction:
+$628.98M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Kiniksa Pharmaceuticals International, plcCL A(KNSA)0918,070+918,070$0$68.50M10.89%+$68.50M
LB Pharmaceuticals Inc(LBRX)01,404,779+1,404,779$0$53.86M8.56%+$53.86M
Relay Therapeutics, Inc.(RLAY)02,984,125+2,984,125$0$53.86M8.56%+$53.86M
Alto Neuroscience, Inc.(ANRO)01,676,558+1,676,558$0$42.80M6.81%+$42.80M
Alkermes plcSHS(ALKS)0948,471+948,471$0$38.43M6.11%+$38.43M
Entera Bio LtdSHS011,213,455+11,213,455$0$32.63M5.19%+$32.63M
Dianthus Therapeutics, Inc.(DNTH)0354,816+354,816$0$31.24M4.97%+$31.24M
Savara Inc.(SVRA)05,381,941+5,381,941$0$27.77M4.42%+$27.77M
Zai Lab LimitedADR(ZLAB)01,042,158+1,042,158$0$27.45M4.36%+$27.45M
Relmada Therapeutics Inc06,912,191+6,912,191$0$26.06M4.14%+$26.06M
Vaxcyte, Inc.(PCVX)0306,047+306,047$0$17.41M2.77%+$17.41M
Obsidian Therapeutics Inc01,249,943+1,249,943$0$17.16M2.73%+$17.16M
Enliven Therapeutics Inc0329,006+329,006$0$15.08M2.40%+$15.08M
Enanta Pharmaceuticals Inc01,088,731+1,088,731$0$14.35M2.28%+$14.35M
Surrozen Inc0432,040+432,040$0$13.90M2.21%+$13.90M
Sagimet Biosciences IncCOM SER A01,400,000+1,400,000$0$13.83M2.20%+$13.83M
Yarrow Bioscience Inc0607,382+607,382$0$13.68M2.17%+$13.68M
Inflarx Nv06,086,170+6,086,170$0$10.96M1.74%+$10.96M
Korsana Biosciences Inc0338,951+338,951$0$10.30M1.64%+$10.30M
Perspective Therapeutics Inc03,693,931+3,693,931$0$10.16M1.62%+$10.16M
An2 Therapeutics Inc01,752,011+1,752,011$0$9.32M1.48%+$9.32M
Inhibikase Therapeutics Inc03,581,603+3,581,603$0$7.36M1.17%+$7.36M
Sab Biotherapeutics Inc02,198,502+2,198,502$0$6.97M1.11%+$6.97M
Century Therapeutics Inc04,059,054+4,059,054$0$6.94M1.10%+$6.94M
Erasca, Inc.(ERAS)0422,543+422,543$0$6.19M0.98%+$6.19M
Achieve Life Science Inc0736,637+736,637$0$5.96M0.95%+$5.96M
Minerva Neurosciences Inc01,655,500+1,655,500$0$5.55M0.88%+$5.55M
Research Alliance Corp IiiCL A
ORD SHS CL A
0500,000+500,000$0$5.42M0.86%+$5.42M
Research Alliance Corp IvCL A0450,000+450,000$0$5.40M0.86%+$5.40M
Helix Acquisition Corp IiiCL A0500,000+500,000$0$5.31M0.84%+$5.31M
Attovia Therapeutics Inc0228,295+228,295$0$3.91M0.62%+$3.91M
Alector Inc02,101,068+2,101,068$0$3.89M0.62%+$3.89M
Tcgx Acquisition CorpCL A0300,000+300,000$0$3.75M0.60%+$3.75M
Lexeo Therapeutics Inc0928,593+928,593$0$3.14M0.50%+$3.14M
Alumis Inc0392,574+392,574$0$2.90M0.46%+$2.90M
Corvus Pharmaceuticals, Inc.(CRVS)0231,585+231,585$0$2.67M0.42%+$2.67M
Jatt Ii Acquisition Corp0160,000+160,000$0$1.80M0.29%+$1.80M
Jatt Iii Acquisition Corp0150,000+150,000$0$1.65M0.26%+$1.65M
Leonabio Inc0393,701+393,701$0$1.41M0.22%+$1.41M
Page 1 of 1